Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry,address2
t0,DMTRF,1660000000.0,42906800,239000000,,-445000000,,-446000000,654000000,96000000,-797000000,-797000000,,-1000000,,,,1000000,319000000,1116000000,223000000,352000000,,-446000000,-446000000,10302000000.0,1848000000.0,1660000000.0,243000000.0,3508000000.0,10312000000.0,612000000.0,-19168000000.0,25000000.0,214000000.0,1000000.0,1137000000.0,773000000.0,214000000.0,3475000000.0,32000000.0,149000000.0,1050000000.0,1577000000.0,0,2702000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,2.56,1630072588,0.0,2.56,2.56,2.56,1200,2.56,finmb_42219841,Other OTC,"3-D Matrix, Ltd.",JPY,237,550,0.22000003,0.09401711,2.34 - 3.9652,-1.4052,-0.35438314,2.34,3.9652,REGULAR,us_market,3-D MATRIX LTD,0,False,False,4,0.0,2.56 - 2.56,-0.615,44.069,2.890361,-0.33036113,-0.11429753,2.7031112,-0.14311123,-0.05294315,99723776,0.05809072,15,America/New_York,EDT,-14400000,1.31,,,3.9652,2.34,2.8904,2.7031,237,550,42.91M,,40.22M,10.05%,2.53%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2021","Apr 29, 2021",-196.48%,-258.69%,-50.00%,-188.65%,1.02B,25.26,92.20%,304M,,-2.01B,-0.6150,,1.14B,24.13,1.46B,87.77,4.49,44.07,-3.25B,-2.47B,Value,102-0083,Healthcare,69,"3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.",Tokyo,81 3 3511 3440,Japan,http://www.3d-matrix.co.jp,86400,Kojimachi HF Building,81 3 3511 3402,Medical Devices,7th Floor 3-2-4 Kojimachi Chiyoda-ku
t-1,DMTRF,1854000000.0,42906800,176000000,,-479000000,,-479000000,577000000,78000000,-675000000,-675000000,,-1000000,,,,0,233000000,908000000,155000000,196000000,,-479000000,-479000000,10006000000.0,1813000000.0,1854000000.0,345000000.0,3667000000.0,10016000000.0,640000000.0,-18721000000.0,11000000.0,553000000.0,1000000.0,1308000000.0,752000000.0,553000000.0,3635000000.0,31000000.0,119000000.0,1050000000.0,1568000000.0,0,2883000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,2.56,1630072588,0.0,2.56,2.56,2.56,1200,2.56,finmb_42219841,Other OTC,"3-D Matrix, Ltd.",JPY,237,550,0.22000003,0.09401711,2.34 - 3.9652,-1.4052,-0.35438314,2.34,3.9652,REGULAR,us_market,3-D MATRIX LTD,0,False,False,4,0.0,2.56 - 2.56,-0.615,44.069,2.890361,-0.33036113,-0.11429753,2.7031112,-0.14311123,-0.05294315,99723776,0.05809072,15,America/New_York,EDT,-14400000,1.31,,,3.9652,2.34,2.8904,2.7031,237,550,42.91M,,40.22M,10.05%,2.53%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2021","Apr 29, 2021",-196.48%,-258.69%,-50.00%,-188.65%,1.02B,25.26,92.20%,304M,,-2.01B,-0.6150,,1.14B,24.13,1.46B,87.77,4.49,44.07,-3.25B,-2.47B,Value,102-0083,Healthcare,69,"3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.",Tokyo,81 3 3511 3440,Japan,http://www.3d-matrix.co.jp,86400,Kojimachi HF Building,81 3 3511 3402,Medical Devices,7th Floor 3-2-4 Kojimachi Chiyoda-ku
t-2,DMTRF,2133000000.0,42906800,162000000,,-679000000,,-679000000,488000000,89000000,-561000000,-561000000,,-1000000,,,,0,263000000,824000000,174000000,-118000000,,-679000000,-679000000,9831000000.0,1834000000.0,2133000000.0,366000000.0,3967000000.0,9841000000.0,412000000.0,-18243000000.0,12000000.0,704000000.0,,1884000000.0,772000000.0,704000000.0,3938000000.0,29000000.0,178000000.0,1050000000.0,1464000000.0,0,3166000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,2.56,1630072588,0.0,2.56,2.56,2.56,1200,2.56,finmb_42219841,Other OTC,"3-D Matrix, Ltd.",JPY,237,550,0.22000003,0.09401711,2.34 - 3.9652,-1.4052,-0.35438314,2.34,3.9652,REGULAR,us_market,3-D MATRIX LTD,0,False,False,4,0.0,2.56 - 2.56,-0.615,44.069,2.890361,-0.33036113,-0.11429753,2.7031112,-0.14311123,-0.05294315,99723776,0.05809072,15,America/New_York,EDT,-14400000,1.31,,,3.9652,2.34,2.8904,2.7031,237,550,42.91M,,40.22M,10.05%,2.53%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2021","Apr 29, 2021",-196.48%,-258.69%,-50.00%,-188.65%,1.02B,25.26,92.20%,304M,,-2.01B,-0.6150,,1.14B,24.13,1.46B,87.77,4.49,44.07,-3.25B,-2.47B,Value,102-0083,Healthcare,69,"3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.",Tokyo,81 3 3511 3440,Japan,http://www.3d-matrix.co.jp,86400,Kojimachi HF Building,81 3 3511 3402,Medical Devices,7th Floor 3-2-4 Kojimachi Chiyoda-ku
t-3,DMTRF,2241000000.0,42906800,208000000,,-408000000,,-408000000,449000000,41000000,-616000000,-616000000,,-1000000,,,,0,209000000,825000000,168000000,208000000,,-408000000,-408000000,9582000000.0,2204000000.0,2241000000.0,657000000.0,4445000000.0,9593000000.0,404000000.0,-17563000000.0,4000000.0,629000000.0,1000000.0,2196000000.0,1063000000.0,629000000.0,4414000000.0,30000000.0,151000000.0,1137000000.0,1663000000.0,0,3351000000.0,en-US,US,EQUITY,False,Delayed Quote,PNK,USD,2.56,1630072588,0.0,2.56,2.56,2.56,1200,2.56,finmb_42219841,Other OTC,"3-D Matrix, Ltd.",JPY,237,550,0.22000003,0.09401711,2.34 - 3.9652,-1.4052,-0.35438314,2.34,3.9652,REGULAR,us_market,3-D MATRIX LTD,0,False,False,4,0.0,2.56 - 2.56,-0.615,44.069,2.890361,-0.33036113,-0.11429753,2.7031112,-0.14311123,-0.05294315,99723776,0.05809072,15,America/New_York,EDT,-14400000,1.31,,,3.9652,2.34,2.8904,2.7031,237,550,42.91M,,40.22M,10.05%,2.53%,,,,,,,,,,,0.00%,,,,,"Apr 29, 2021","Apr 29, 2021",-196.48%,-258.69%,-50.00%,-188.65%,1.02B,25.26,92.20%,304M,,-2.01B,-0.6150,,1.14B,24.13,1.46B,87.77,4.49,44.07,-3.25B,-2.47B,Value,102-0083,Healthcare,69,"3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.",Tokyo,81 3 3511 3440,Japan,http://www.3d-matrix.co.jp,86400,Kojimachi HF Building,81 3 3511 3402,Medical Devices,7th Floor 3-2-4 Kojimachi Chiyoda-ku
